The Senate today passed and sent to the president for his signature the Formula Act (H.R. 8351), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.

Related News Articles

Headline
The Centers for Medicare & Medicaid Services yesterday approved state plan amendments allowing Georgia and Pennsylvania to extend postpartum coverage from…
Headline
In recognition of National Women’s Blood Pressure Awareness Week, Oct. 17-23, Shanna Cox, associate director for science at the Centers for Disease Control and…
Headline
The Centers for Disease Control and Prevention today recommended Moderna’s bivalent COVID-19 vaccine booster for children aged 6-17 and Pfizer’s bivalent COVID…
Headline
The Food and Drug Administration Friday authorized for emergency use the first commercial test kit to detect monkeypox in lesion swab specimens. Only…
Headline
Hypertension while pregnant or postpartum can increase the risk of other complications that impact the mom and baby. Alison Williams, vice president of…
Headline
The Centers for Medicare & Medicaid Services today approved Medicaid demonstrations for Oregon and Massachusetts that will test innovative approaches…